Core Insights - Tectonic Therapeutic, Inc. is a clinical stage biotechnology company focused on developing therapeutic proteins and antibodies targeting G-protein coupled receptors (GPCRs) [1][5] - The company will participate in two investor conferences in March 2025, providing opportunities for engagement with investors [1][4] Conference Details - Tectonic will present at the TD Cowen 45 Annual Health Care Conference on March 5, 2025, at 9:50 AM EST in Boston, MA, with Alise Reicin, MD, as the presenter [2] - The company will also participate in the Leerink Partners Global Healthcare Conference on March 11, 2025, at 11:20 AM EDT in Miami, FL, featuring Daniel Lochner and Marc Schwabish, PhD, as presenters [3] - Both conferences will include live webcasts accessible on Tectonic's website, with replays available for approximately 90 days post-event [3] Company Overview - Tectonic utilizes its proprietary GEODe™ technology platform to enhance GPCR-targeted drug discovery, aiming to develop biologic medicines for significant unmet medical needs [5] - The company is headquartered in Watertown, Massachusetts, and focuses on areas where therapeutic options are limited, aiming to improve patient quality of life [5]
Tectonic Therapeutic to Participate in March Investor Conferences